Results 11 to 20 of about 2,491,529 (292)

Cytotoxicity and effect on wound re‐epithelialization after topical administration of tranexamic acid

open access: yesBJS Open, 2019
Background Topical administration of tranexamic acid (TXA) reduces bleeding from surgical wounds similarly to intravenous use, but with negligible risk of adverse systemic events. Topical use is expanding, but is off‐label.
T. A. Eikebrokk   +5 more
doaj   +2 more sources

TOPICAL NONSTEROID ANTI-INFLAMATORY DRUGS – INDICATIONS, EFFICACY AND SAFETY [PDF]

open access: yesRomanian Journal of Rheumatology, 2019
Topical Nonsteroid anti-inflammatory drugs are efficient for the treatment of acute and chronic pain in musculo-skeletal diseases. There clinical benefit is similar to the oral form of administration, but with significant less systemic adverse events ...
Diana Mazilu, Ruxandra Ionescu
doaj   +3 more sources

Delivery of biologics: Topical administration. [PDF]

open access: yesBiomaterials, 2023
Biologics are unaffordable to a large majority of the global population because of prohibitively expensive fermentation systems, purification and the requirement for cold chain for storage and transportation. Limitations of current production and delivery systems of biologics were evident during the recent pandemic when 90% are delivered using invasive
Kulchar RJ   +5 more
europepmc   +5 more sources

Immunologic Corneal Graft Rejection after Administration of Topical Latanoprost: a Report of Two Patients [PDF]

open access: yesJournal of Ophthalmic & Vision Research, 2011
Purpose: To report endothelial corneal graft rejection after administration of topical latanoprost eye drops. Case Report: Two eyes of two patients with a history of multiple intraocular procedures prior to penetrating keratoplasty developed endothelial
Kouros Nouri-Mahdavi   +2 more
doaj   +1 more source

The use of topical diclofenac in the pain management of osteoarthritis of the knee [PDF]

open access: yes, 2006
Osteoarthritis (OA) is a common complaint that affects millions of people worldwide. As there is no cure for OA, drug treatment is the main form of management.
Banning, M
core   +6 more sources

Recent advances in topical therapeutics for vitreoretinal diseases [PDF]

open access: yes, 2015
Eye drops are convenient for patients, but achieving therapeutic doses and maintaining sustained drug release without frequent re-application to treat diseases of the retina has been largely unsuccessful.
Gibson, Jonathan, McGinnigle, Samantha
core   +7 more sources

Topical diclofenac: Clinical effectiveness and current uses in osteoarthritis of the knee and soft tissue injuries [PDF]

open access: yes, 2008
Background: Diclofenac is a commonly used non-steroidal anti-inflammatory drug (NSAID) for symptom control in osteoarthritis (OA) of the knee and soft tissue injuries.
Banning, M
core   +1 more source

Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility

open access: yesBMC Veterinary Research, 2021
Background Topical ophthalmic atropine sulfate is an important part of the treatment protocol in equine uveitis. Frequent administration of topical atropine may cause decreased intestinal motility and colic in horses due to systemic exposure.
L. Ström   +7 more
doaj   +1 more source

Bisphosphonate: Brief Review of Its Development for Usage in Dentistry

open access: yesJournal of Dentistry Indonesia, 2013
Bisphosphonate (BP) is a class of drug that prevent the loss of bone mass. It inhibits the resorption of bone by encouraging osteoclast to undergo apoptosis.
Tita Ratya Utari
doaj   +1 more source

Microneedles enhance the efficacy of topical dental anesthesia in male subjects: a randomized controlled trial [PDF]

open access: yesBrazilian Oral Research
: This study aimed to determine whether microneedles (MN) can enhance the efficacy of a commercially available topical anesthetic (EMLA®) when applied to the palatal mucosa.
Stephany Di Carla Santos   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy